Remitch nalfurafine regulatory update

Toray submitted a regulatory application in Japan to expand the label of Remitch nalfurafine to include the improvement of pruritus in patients with chronic liver disease. The kappa opioid receptor ( KOR) agonist is already approved to treat pruritus in hemodialysis patients. ...